- Home
- CRDF vs FTLF Comparison
CRDF vs FTLF Comparison
Compare CRDF & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- FTLF
- Stock Information
- Founded
- CRDF 1999
- FTLF 2005
- Country
- CRDF United States
- FTLF United States
- Employees
- CRDF N/A
- FTLF N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- FTLF Medicinal Chemicals and Botanical Products
- Sector
- CRDF Health Care
- FTLF Health Care
- Exchange
- CRDF Nasdaq
- FTLF Nasdaq
- Market Cap
- CRDF 143.4M
- FTLF 151.0M
- IPO Year
- CRDF N/A
- FTLF N/A
- Fundamental
- Price
- CRDF $2.58
- FTLF $30.26
- Analyst Decision
- CRDF Strong Buy
- FTLF Strong Buy
- Analyst Count
- CRDF 3
- FTLF 1
- Target Price
- CRDF $9.33
- FTLF $40.00
- AVG Volume (30 Days)
- CRDF 1.1M
- FTLF 20.7K
- Earning Date
- CRDF 11-07-2024
- FTLF 11-14-2024
- Dividend Yield
- CRDF N/A
- FTLF N/A
- EPS Growth
- CRDF N/A
- FTLF 93.76
- EPS
- CRDF N/A
- FTLF 1.70
- Revenue
- CRDF $688,000.00
- FTLF $62,756,000.00
- Revenue This Year
- CRDF $15.00
- FTLF $29.71
- Revenue Next Year
- CRDF N/A
- FTLF $10.28
- P/E Ratio
- CRDF N/A
- FTLF $17.79
- Revenue Growth
- CRDF 49.57
- FTLF 40.17
- 52 Week Low
- CRDF $1.07
- FTLF $18.86
- 52 Week High
- CRDF $6.42
- FTLF $35.49
- Technical
- Relative Strength Index (RSI)
- CRDF 41.24
- FTLF 38.35
- Support Level
- CRDF $2.85
- FTLF $31.12
- Resistance Level
- CRDF $4.38
- FTLF $35.49
- Average True Range (ATR)
- CRDF 0.45
- FTLF 1.48
- MACD
- CRDF -0.10
- FTLF 0.02
- Stochastic Oscillator
- CRDF 2.70
- FTLF 27.43
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, and sports drink products, meal replacement products and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products and Supplements.